BALCHEM CORP (BCPC) Stock Price, Forecast & Analysis
USA - NASDAQ:BCPC - US0576652004 - Common Stock
BCPC Key Statistics, Chart & Performance
The current stock price of BCPC is 156.75 USD. In the past month the price increased by 6.21%. In the past year, price decreased by -11.82%.
BCPC Latest News, Press Relases and Analysis
BCPC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SHW | SHERWIN-WILLIAMS CO/THE | 29.37 | 82.82B | ||
| ECL | ECOLAB INC | 35.57 | 73.34B | ||
| PPG | PPG INDUSTRIES INC | 12.63 | 21.90B | ||
| IFF | INTL FLAVORS & FRAGRANCES | 15.08 | 16.88B | ||
| DD | DUPONT DE NEMOURS INC | 9.09 | 16.63B | ||
| RPM | RPM INTERNATIONAL INC | 19.99 | 13.69B | ||
| ALB | ALBEMARLE CORP | N/A | 13.55B | ||
| NEU | NEWMARKET CORP | 16.57 | 7.37B | ||
| EMN | EASTMAN CHEMICAL CO | 9.24 | 6.92B | ||
| AXTA | AXALTA COATING SYSTEMS LTD | 11.56 | 6.26B | ||
| ESI | ELEMENT SOLUTIONS INC | 17.61 | 6.26B | ||
| CE | CELANESE CORP | 8.11 | 4.26B |
Related stock screener links
About BCPC
Company Profile
Balchem Corp. provides marketing of specialty performance ingredients and products. The company is headquartered in Montvale, New Jersey and currently employs 1,364 full-time employees. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Company Info
BALCHEM CORP
5 Paragon Drive
Montvale NEW JERSEY 10958 US
CEO: Theodore L. Harris
Employees: 1364
Phone: 18453265600
BALCHEM CORP / BCPC FAQ
What does BALCHEM CORP do?
Balchem Corp. provides marketing of specialty performance ingredients and products. The company is headquartered in Montvale, New Jersey and currently employs 1,364 full-time employees. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
What is the current price of BCPC stock?
The current stock price of BCPC is 156.75 USD. The price decreased by -0.15% in the last trading session.
Does BCPC stock pay dividends?
BALCHEM CORP (BCPC) has a dividend yield of 0.55%. The yearly dividend amount is currently 0.79.
How is the ChartMill rating for BALCHEM CORP?
BCPC has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What is the GICS sector and industry of BCPC stock?
BALCHEM CORP (BCPC) operates in the Materials sector and the Chemicals industry.
What is the Price/Earnings (PE) ratio of BALCHEM CORP (BCPC)?
The PE ratio for BALCHEM CORP (BCPC) is 31.54. This is based on the reported non-GAAP earnings per share of 4.97 and the current share price of 156.75 USD.
What is the market capitalization of BCPC stock?
BALCHEM CORP (BCPC) has a market capitalization of 5.09B USD. This makes BCPC a Mid Cap stock.
BCPC Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to BCPC. When comparing the yearly performance of all stocks, BCPC is a bad performer in the overall market: 73.39% of all stocks are doing better.
BCPC Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to BCPC. BCPC has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
BCPC Financial Highlights
Over the last trailing twelve months BCPC reported a non-GAAP Earnings per Share(EPS) of 4.97. The EPS increased by 18.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.72% | ||
| ROA | 8.98% | ||
| ROE | 11.5% | ||
| Debt/Equity | 0.12 |
BCPC Forecast & Estimates
8 analysts have analysed BCPC and the average price target is 204.68 USD. This implies a price increase of 30.58% is expected in the next year compared to the current price of 156.75.
For the next year, analysts expect an EPS growth of 19.93% and a revenue growth 8.15% for BCPC